A PILOT RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL DESIGN, MULTICENTER TRIAL TO EVALUATE THE EFFECT OF RANITIDINE ON IMMUNOLOGIC INDICATORS IN ASYMPTOMATIC HIV-1 INFECTED SUBJECTS WITH A CD4 CELL COUNT BETWEEN 400-700 CELLS/MM3: